Trial Profile
Prospective Multicenter Observational Program for Evaluation of Efficacy and Tolerability of the 6-month Depot Eligard 45 mg in Patients With Advanced Prostate Carcinoma in Routine Clinical Practice of Uro-Oncologists in the Russian Federation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 15 Aug 2016 Status changed from active, no longer recruiting to completed.
- 07 Jul 2014 New trial record
- 02 Jul 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.